degraded by
the 26S proteasome in an ATP-dependent process, and
free ubiquitin is released.4-7
Reagent
S-100 Proteasome Fraction is supplied as a solution in
50 mM HEPES, pH 7.6, 20 mM NaCl, 0.5 mM
Leu15]-Gastrin I, reconstituted to 100 μM in PBS/ 0.1% BSA Sigma G9145 10 µL 20 nM
Prostaglandin E2, reconstituted to 100 μM in DMSO Sigma P6532 10 µL 20 nM
A-83-01, reconstituted to 1 mM in
Leu15]-Gastrin I, reconstituted to 100 μM in PBS/ 0.1% BSA Sigma G9145 10 µL 20 nM
Prostaglandin E2, reconstituted to 100 μM in DMSO Sigma P6532 10 µL 20 nM
A-83-01, reconstituted to 1 mM in
1982).
2. Mosmann, T., et al., Proc. Nat. Acad. Sci. USA, 83,
5654 (1986).
3. Paul, W., and Ohara, J., Ann. Rev. Immunol., 5,
429 (1987).
4. Park, L., et al., J. Exp. Med., 166, 476 (1987).
5. Jung
1982).
2. Mosmann, T., et al., Proc. Nat. Acad. Sci. USA, 83,
5654 (1986).
3. Paul, W., and Ohara, J., Ann. Rev. Immunol., 5,
429 (1987).
4. Park, L., et al., J. Exp. Med., 166, 476 (1987).
5. Jung
7251 (1987).
3. Van Snick, J., Ann. Rev. Immunol., 8., 253
(1990).
4. Van Snick, J., et al., Proc. Natl. Acad. Sci.
USA, 83, 9679 (1986).
5. Jung, T., et al., J. Immunol. Methods, 159, 197
Potential anticancer agents.
LXI. A novel synthesis of "spongo" nucleosides.
J. Am. Chem. Soc., 83, 2208 (1961).
2. Rubsam, L. Z., et al., Superior cytotoxicity with
ganciclovir compared with
F., et al., Proc. Natl. Acad. Sci., USA, 83, 2061
(1986).
2. Noma, Y., Nature, 319, 640 (1986).
3. Howard, M., et al., J. Exp. Med., 155, 914 (1982).
4. Roehm, N.W., et al., J. Exp. Med., 160
Langenbach, R., et al., Cell, 83, 483 (1995).
9. O’Neill, P. O., and Ford-Hutchinson, A. W., FEBS
Letts., 330, 156 (1993).
10. Tsujii, M., and DuBois, R. N., Cell, 83, 493 (1995).
KAA 06/01
Lee, F., et al., Proc. Natl. Acad. Sci., USA, 83,
2061(1986).
2. Noma, Y., Nature, 319, 640 (1986).
3. Howard, M., et al., J. Exp. Med., 155, 914 (1982).
4. Roehm, N.W., et al., J. Exp. Med., 160, 679
Motility and the Cytoskeleton 8:210.
7. Wood, J.G. et al. (1986) PNAS.USA 83:4040.
8. Grundke, Iqbal et al. (1986) PNAS.USA 83:4913.
9. Shelanski, M.L. et al. (1973) PNAS.USA 70:765.
10. Hsu, S. et
0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼83 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 83–113 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This
function relationship of follicle-stimulating hormone
and its receptor. Hum. Reprod. Update, 4(3), 260-
83 (1998).
3. Desai, M.P. et al., Importance of selection of
separation system in the development
0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼83 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 83–113 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This
mM NaCl, 0.25 mM DTT, 0.1 mM
EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼83 kDa
Precautions and Disclaimer
This product is for R&D use only, not for drug,
household, or other
0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼83 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 83–113 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This
0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼83 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 83–113 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This
0.1 mM EDTA, 0.1 mM PMSF, and 25%
glycerol.
Molecular mass: ∼83 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 83–113 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This